Trials / Withdrawn
WithdrawnNCT04086810
An Open-Label Study of DCCR Tablet in Patients With PWS
An Open-Label Study of Diazoxide Choline Controlled-Release Tablet in Patients With Prader-Willi Syndrome
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Soleno Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 4 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to monitor the long-term safety of DCCR in PWS patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DCCR | Once daily oral administration |
Timeline
- Start date
- 2019-10-01
- Primary completion
- 2019-10-01
- Completion
- 2019-10-01
- First posted
- 2019-09-12
- Last updated
- 2021-08-03
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04086810. Inclusion in this directory is not an endorsement.